Opinion|Videos|September 6, 2024
Barriers to Administering Pneumococcal Vaccines and Best Practices for Overcoming Them
The panel explores potential barriers to administering newer pneumococcal vaccines, such as payer coverage and patient concerns, while also discussing effective strategies for patient education and emphasizing the necessity and benefits of pneumococcal immunization.
Advertisement
Episodes in this series
- What are potential obstacles related to administering newer pneumococcal vaccines (i.e., payer coverage, patient concerns, etc.)?
- What are the best ways to educate patients and emphasize the need and benefits associated with immunizing against pneumococcal disease?
- What are the benefits of the PneumoRecs Vax advisor and how do you utilize this for your patients?
Advertisement
Related to this article
Early data suggest the 7 PCV20-added serotypes are causing a smaller share of invasive pneumococcal disease in children younger than 2 years.
Advertisement
Advertisement
Trending on Pharmacy Times
1
PCSK9 Inhibition Lowers LDL-C in Patients With Kidney Disease
2
Walgreens Adds Pharmacist Outreach, Coverage Help for GLP-1s
3
GLP-1 RAs Tied to Lower Kidney Failure Risk in Patients With Obesity, CKD
4
The Growing Role the Specialty Pharmacy Team Plays in Helping Breast Cancer Patients Navigate Treatment
5